# Anti-thrombotic Monotherapy With the HeartMate 3 LVAS

> **NCT03704220** · NA · UNKNOWN · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 10 (estimated)

## Conditions studied

- Heart Failure
- Cardiovascular Diseases

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03704220
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-16
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03704220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03704220, "Anti-thrombotic Monotherapy With the HeartMate 3 LVAS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03704220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*